HOPX and colitis: To evaluate if the emerging Hopx+ CARSCs play a functional role in colitis-associated crypt regeneration, we ablated this population in the HopxCreER/RosaDTR line at the hypertrophic stage by diphtheria toxin (DT) injection beginning at 14 days post DSS injury (Figure 1I).